Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Commercial AI solutions in detecting COVID-19 pneumonia in chest CT: not yet ready for clinical implementation?
12
Zitationen
12
Autoren
2021
Jahr
Abstract
• Commercial AI solutions achieved a sensitivity and specificity ranging from 62 to 96% and from 31 to 80%, respectively, in identifying patients suspicious for COVID-19 in a clinical dataset. • Sensitivity remained within the same range, while specificity was even lower in subgroup analysis of CT studies with ground-glass opacities, and interrater agreement between the commercial AI solutions was minimal to nonexistent. • Thus, commercial AI solutions have the potential to be integrated as alert tools for the detection of patients with lung changes suspicious for COVID-19 pneumonia in a clinical routine workflow, if further improvement is made.
Ähnliche Arbeiten
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
2020 · 22.609 Zit.
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
2020 · 19.271 Zit.
A Multi-Modal Distributed Real-Time IoT System for Urban Traffic Control (Invited Paper)
2024 · 14.254 Zit.
UNet++: A Nested U-Net Architecture for Medical Image Segmentation
2018 · 8.503 Zit.
Review of deep learning: concepts, CNN architectures, challenges, applications, future directions
2021 · 7.117 Zit.